IPSC vs TXN · rev $6.6M vs P/E 52, rev $17.68B
Century Therapeutics Inc (IPSC) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
IPSC currently screens at market cap $47.8M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the IPSC and TXN stock pages for the full models.
Not investment advice.